GlassScriptPhysician profile
Karl Richardson
NPI 1609194372
$8,408.20
in general payments reported to CMS, 2019-2025
10 companies · $2,074 in 2025
The $2,074 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2021: $212 · 2022: $498 · 2023: $2,412 · 2024: $3,072 · 2025: $2,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,343 · Food and Beverage: $2,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,342.82 |
| Food and Beverage | $2,215.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,955.64 | 2022-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,545.19 | 2023-2025 | Amplatzer Amulet, Mitraclip, Triclip |
| Boston Scientific Corporation | $2,342.84 | 2019-2025 | Watchman Access System, General - Therapies, Watchman Flx |
| Biosense Webster, INC. | $118.65 | 2024 | Nuvision Ice Catheter |
| Abiomed | $108.80 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.06 | 2025 | Lifevest |
| Medtronic, INC. | $90.95 | 2024 | Corevalve Evolut R |
| Philips North America LLC | $73.87 | 2022 | |
| Siemens Medical Solutions USA, INC. | $57.36 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Amgen INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.